Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Reiser

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
Onkologie|November 10, 2007
Lyme disease in a patient with chronic lymphocytic leukemia mimics leukemic meningeosisCarmen D Schweighofer, Gerd Fätkenheuer, Peter Staib, et al.
British Journal of Haematology|March 10, 2005
Prediction of individual response to chemotherapy in patients with acute myeloid leukaemia using the chemosensitivity index CiPeter Staib, Elke Staltmeier, Katja Neurohr, et al.
Oncology Research and Treatment|November 29, 2017
Successful Evidence-Based Treatment of Patients with Advanced Pancreatic Cancer in Community-Based Oncology Group PracticesGeothy Chakupurakal, Stefan Feiten, Oswald Burkhard, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 5, 2024
Association between serum IgG concentrations and the incidence of infections in patients with chronic lymphocytic leukemia and secondary immunodeficiency under treatment with PrivigenBurkhard Otremba, Ferdinand Haslbauer, Marcel Reiser, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 15, 2009
Long-term outcome and prognostic factors in early-stage nodal low-grade non-hodgkin's lymphomas treated with radiation therapyHans Theodor Eich, Martina Heimann, Hartmut Stützer, et al.
Acta Haematologica|December 27, 2021
Romiplostim for Primary Immune Thrombocytopenia in Routine Clinical Practice: Results from a Multicentre Observational Study in GermanyMarcel Reiser, Klaus M Josten, Hermann Dietzfelbinger, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 24, 2026
Effectiveness and safety of pegylated filgrastim (Pelgraz®) for the prevention of febrile neutropenia during cancer chemotherapy in all-day practice in GermanyTilman Steinmetz, Peter Jungberg, Dagmar Guth, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 1, 2006
Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patientSabine Awerkiew, Martin Däumer, Marcel Reiser, et al.
Medizinische Klinik (Munich, Germany : 1983)|September 30, 2010
[Assessment of immunoglobulins in a long-term non-interventional study (SIGNS Study). Rationale, design, and methods]Wilhelm Kirch, Ralf Gold, Manfred Hensel, et al.
Journal of Clinical Immunology|September 15, 2012
Treatment of neurological autoimmune diseases with immunoglobulins: first insights from the prospective SIGNS registryMartin Stangel, Ulrich Baumann, Michael Borte, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Onkologie|November 10, 2007
Lyme disease in a patient with chronic lymphocytic leukemia mimics leukemic meningeosisCarmen D Schweighofer, Gerd Fätkenheuer, Peter Staib, et al.
British Journal of Haematology|March 10, 2005
Prediction of individual response to chemotherapy in patients with acute myeloid leukaemia using the chemosensitivity index CiPeter Staib, Elke Staltmeier, Katja Neurohr, et al.
Oncology Research and Treatment|November 29, 2017
Successful Evidence-Based Treatment of Patients with Advanced Pancreatic Cancer in Community-Based Oncology Group PracticesGeothy Chakupurakal, Stefan Feiten, Oswald Burkhard, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 5, 2024
Association between serum IgG concentrations and the incidence of infections in patients with chronic lymphocytic leukemia and secondary immunodeficiency under treatment with PrivigenBurkhard Otremba, Ferdinand Haslbauer, Marcel Reiser, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 15, 2009
Long-term outcome and prognostic factors in early-stage nodal low-grade non-hodgkin's lymphomas treated with radiation therapyHans Theodor Eich, Martina Heimann, Hartmut Stützer, et al.
Acta Haematologica|December 27, 2021
Romiplostim for Primary Immune Thrombocytopenia in Routine Clinical Practice: Results from a Multicentre Observational Study in GermanyMarcel Reiser, Klaus M Josten, Hermann Dietzfelbinger, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 24, 2026
Effectiveness and safety of pegylated filgrastim (Pelgraz®) for the prevention of febrile neutropenia during cancer chemotherapy in all-day practice in GermanyTilman Steinmetz, Peter Jungberg, Dagmar Guth, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 1, 2006
Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patientSabine Awerkiew, Martin Däumer, Marcel Reiser, et al.
Medizinische Klinik (Munich, Germany : 1983)|September 30, 2010
[Assessment of immunoglobulins in a long-term non-interventional study (SIGNS Study). Rationale, design, and methods]Wilhelm Kirch, Ralf Gold, Manfred Hensel, et al.
Journal of Clinical Immunology|September 15, 2012
Treatment of neurological autoimmune diseases with immunoglobulins: first insights from the prospective SIGNS registryMartin Stangel, Ulrich Baumann, Michael Borte, et al.
Pageof 8